Search

everythinglearnresearchcommunity

for

Search:↓

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Selenium shows promise in preventing and controlling prostate cancer.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Human hair-derived particles can effectively carry and release the cancer drug Paclitaxel in a pH-sensitive manner, potentially targeting cancer cells while sparing healthy ones.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

Breast pain is common and usually not linked to cancer, with treatment varying by severity.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Dermatologists should carefully manage hair loss in cancer patients to improve their quality of life.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

Losing both ERBB2 and ERBB3 receptors in mice causes significant skin problems and inflammation.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Cutaneous vesicostomy and cystoscopic valve ablation both have pros and cons for managing posterior urethral valves.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

Nutritional education reduces chemotherapy side effects and improves health in breast cancer patients.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Chemotherapy harms healthy cells, causing side effects like hair loss and reduced immunity.

Low-dose methotrexate is generally safe but can cause mild to severe side effects, and folic acid can reduce these risks.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Better awareness of chemotherapy's side effects improves self-care.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

EGFR inhibitors cause skin issues and hair loss by weakening skin defenses, suggesting antibiotics and targeted treatments can help.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.